Medac Pharma: Medac Pharma Announces Settlement Of Patent Infringement Lawsuits

Medac Pharma, Inc., a privately-held pharmaceutical company, today announced that it and its parent company, medac GmbH, have settled all litigation and patent office proceedings with Antares Pharma, Inc. Pursuant to the settlement agreement, the parties will dismiss proceedings related to their respective patents pending before the United States District Court for the District of Delaware, the United States District Court for the District of New Jersey, the Patent Trial and Appeal Board of the U.S.Read more about Medac Pharma Announces Settlement Of Patent Infringement LawsuitsComments